drkoop buys drDrew to reach teen marketdrkoop.com has bought drDrew.com, a healthcare content Web site targeting the 14- to 24-year-old market, for 1.58 million shares in common stock and $150,000 cash. Through the acquisition, which brings
drkoop buys drDrew to reach teen market
drkoop.com has bought drDrew.com, a healthcare content Web site targeting the 14- to 24-year-old market, for 1.58 million shares in common stock and $150,000 cash. Through the acquisition, which brings drkoop's user base to some two million, drkoop hopes to drive additional licensing revenue and leverage this access to the teen/young adult audience. While drDrew.com will continue to operate as a separate site, the two sites will integrate some content. The acquisition was not a risky move for the beleaguered dot-com and drkoop will continue to evaluate acquiring "undervalued properties," said Ed Cespedes, president of drkoop.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.